Antibody concentrations to Aβ1–42 monomer and soluble oligomers in untreated and antibody–antigen-dissociated intravenous immunoglobulin preparations

Diffusible, nonfibrillar ligands derived from Aβ _1–42 are potent central nervous system neurotoxins

Mary P. Lambert, Avlin Barlow, Brett A. Chromy et al. · Proceedings of the National Academy of Sciences · 1998 · 3.5K citations · Full text

Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse

Dale Schenk, Robin Barbour, Whitney Dunn et al. · Nature · 1999 · 3.1K citations

Neurodegenerative Diseases, Alzheimer's Disease, Immunology +7

Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

Frédérique Bard, Catherine Cannon, Robin Barbour et al. · Nature Medicine · 2000 · 2K citations · Full text

Amyloid β-Peptide Enter, Neurodegenerative Diseases, Alzheimer's Disease +13

Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease

Dave Morgan, David M. Diamond, Paul E. Gottschall et al. · Nature · 2000 · 1.5K citations

Vaccination, Neurodegenerative Diseases, Alzheimer's Disease +14

Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial

Clive Holmes, Delphine Boche, David Wilkinson et al. · The Lancet · 2008 · 1.4K citations

Neurodegenerative Diseases, Geriatric Neurology, Alzheimer's Disease +11